3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Esophageal Squamous Cell Carcinoma
4
Advanced Solid Tumor
4
Solid Tumor
3
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Esophageal Neoplasms
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Rectal Neoplasms
2
Melanoma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Advanced Solid Tumour
2
Unresectable Stage III Non-small Cell Lung Cancer
1
Triple Negative Breast Neoplasms
1
Skin Neoplasms
1
Simpson-Golabi-Behmel syndrome
1
Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Interventions
fludarabine
27
Azacitidine
27
venetoclax
24
Cyclophosphamide
22
Specimen Handling
21
fludarabine phosphate
17
Biopsy
16
Whole-Body Irradiation
15
Mycophenolic Acid
15
Busulfan
15
Melphalan
14
Cytarabine
14
Tacrolimus
13
Granulocyte Colony-Stimulating Factor
12
Decitabine
11
Stem Cell Transplantation
10
Injections
10
Cyclosporine
10
decitabine and cedazuridine drug combination
9
Sirolimus
9
Filgrastim
9
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
X-Rays
6
Idarubicin
6
ruxolitinib
5
Cyclosporins
5
Cladribine
5
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
tislelizumab
×
90 days
×
Clear all
No trials found.